ReadyGo Diagnostics
- Company typePrivate
- Founded2019
- HeadquartersChippenham, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
ReadyGo Diagnostics firmographics
Firmographics- Name
- ReadyGo Diagnostics
- Legal name
- ReadyGo Diagnostics Ltd
- Website
- https://readygotest.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
ReadyGo Diagnostics industry classification
Industry- Product category
- Molecular Diagnostics Devices
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics) (HLAHAAAN)
- akta.pro secondary industry
- IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)
Keywords
Where ReadyGo Diagnostics is headquartered
LocationHeadquarters
- HQ city
- Chippenham
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
ReadyGo Diagnostics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
Revenue model
- Diagnostic Device Sales: Sale of Geo™ and SnapShot™ diagnostic instrument platforms for molecular testing. Geo is sold as a reusable modular platform, while SnapShot cartridges are sold as single-use disposables for sample-to-answer testing.
- GoCollect® Collection Materials: Sale of proprietary collection devices (GoCollect Wet, Dry, Plasma, Urine formats) for sample collection and preparation. Supports multiple sample types including saliva, blood, sputum, and urine.
- GoTest™ Reagent Delivery: Sale of pre-treated matrices, reaction zones, and reagent films for OEM integration. Partners can purchase GoTest materials as drop-in components for their own cartridge, strip, or pipette tip products.
- OEM Development Services: Custom assay drying and formulation services converting customers' wet-lab assays into dry formats. Includes rapid prototype-to-pilot scale testing and turnkey OEM manufacturing for partners seeking complete solutions.
Go-to-market motion3 records
Distribution channels3 records
Marketing channels3 records
ReadyGo Diagnostics product offering
Product offeringCore offering
ReadyGo Diagnostics develops and sells proprietary sample collection and reagent delivery consumables that simplify molecular diagnostic workflows. Its core products—GoCollect®, GoTest™, Geo™, and SnapShot™—integrate volumetric sample collection, non-chaotropic lysis, ambient-temperature reagent stabilization, and sample-to-answer detection into disposable cartridges, sold as standalone devices, consumables, and through OEM licensing to assay developers.
Product overview
ReadyGo Diagnostics offers an integrated multi-matrix platform of three core product lines—GoCollect® (smart sampling for saliva, blood, urine, sputum with built-in lysis and stabilization), GoTest™ (air-dried reagent delivery for molecular and biochemical reactions), and Devices (Geo™ modular development platform plus SnapShot™ sealed cartridge for end-users). Together these unite sample capture, processing, stabilization, and analysis into a unified system enabling lab-grade diagnostics anywhere from clinics to homes to field settings.
Differentiator
Problem solved
Functional benefit
Brands
- GoCollect®: Smart sampling technology that unites collection, processing, and elution in a single step, preserving nucleic acids and proteins for molecular, lateral-flow, or biochemical testing.
- GoTest™
- Geo™
- SnapShot™
Products and services
- GoCollect® Smart Sampling Technology
Quantifiable outcome
- Sample-to-result in one sealed, disposable cartridge without complex instruments or trained operators
- +4 more outcomes
Companies that use ReadyGo Diagnostics
Customer profileSegments4 records
Ideal customer profiles4 records
ReadyGo Diagnostics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
ReadyGo Diagnostics partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- SureScreen Diagnostics Ltd.coreCo-development agreement to research, develop, and commercialize a groundbreaking product targeting the drink spike testing market. The partnership combines ReadyGo's advanced sampler technology and proprietary dried reagent technology with SureScreen's proven drug detection assays to create an easy-to-use consumer testing solution.
Scale indicators1 record
Expansion highlights5 records
ReadyGo Diagnostics competitors and assessment
Company assessmentDirect peers
- Genedrive: Genedrive was founded by ReadyGo's CEO Ben Cobb and is described by the company as one of the world's first true point-of-care molecular platforms, now used in NHS standard care. It is the closest comparator both technically (POC molecular cartridge) and founder-lineage-wise.
- Binx Health: Binx Health built the Binx io point-of-care molecular platform, led to commercialisation by ReadyGo NED John Clarkson. Direct peer in single-use cartridge molecular diagnostics for decentralised testing.
- Sense Biodetection: UK-based molecular diagnostics startup developing rapid, instrument-free sample-to-answer tests. Highly comparable in disposable-cartridge POC molecular approach and target use cases.
- QuantuMDx: UK-based developer of a portable, sample-to-answer molecular diagnostic platform (Q-POC) targeting decentralised and resource-limited settings. Direct POC molecular peer with overlapping customer base.
- OraSure Technologies: OraSure specialises in sample collection technologies (including oral fluid and dried blood spot) used for diagnostics and at-home testing. Highly comparable in the sample-collection / decentralised-testing layer of ReadyGo's GoCollect offering.
Broad incumbents
- Cepheid (Danaher): Cepheid's GeneXpert is the dominant cartridge-based POC molecular diagnostics platform globally, used in hospitals, clinics, and large reference labs. Overlaps directly with ReadyGo's SnapShot/cartridge value proposition at much larger scale.
- Abbott (Diagnostics): Abbott markets the ID NOW rapid molecular platform and BinaxNOW rapid antigen tests across POC and at-home settings. It is a broad incumbent in the same decentralised testing markets ReadyGo targets.
- bioMérieux: Global IVD major with a broad molecular diagnostics and industrial microbiology portfolio, including cartridge-based systems. Broad incumbent whose sample-prep and reagent products overlap with ReadyGo's technology layer.
- Hologic (Diagnostics): Hologic's Panther and other molecular systems serve high-throughput clinical diagnostics; broad incumbent competing for the same clinical-laboratory and hospital wallet share that ReadyGo's POC cartridge targets.
Emerging players
- Sherlock Biosciences: Emerging molecular diagnostics company (CRISPR- and synthetic-biology-based) building rapid, deployable tests. Comparable as an emerging player in decentralised molecular diagnostics, though differentiated by detection chemistry.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks7 records
Key highlights6 records
Customer concentration
ReadyGo Diagnostics social profiles
Digital presenceReadyGo Diagnostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
ReadyGo Diagnostics leadership team
Management profileNumber of profiles
Profiles8 records
ReadyGo Diagnostics funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ReadyGo Diagnostics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ReadyGo Diagnostics
What does ReadyGo Diagnostics do?
ReadyGo Diagnostics develops and sells proprietary sample collection and reagent delivery consumables that simplify molecular diagnostic workflows. Its core products—GoCollect®, GoTest™, Geo™, and SnapShot™—integrate volumetric sample collection, non-chaotropic lysis, ambient-temperature reagent stabilization, and sample-to-answer detection into disposable cartridges, sold as standalone devices, consumables, and through OEM licensing to assay developers.
Is ReadyGo Diagnostics a public or private company?
ReadyGo Diagnostics is a private company. It is classified as venture growth investor backed and is currently operating.
When was ReadyGo Diagnostics founded?
ReadyGo Diagnostics was founded in 2019. It employs 11 to 50 people.
Where is ReadyGo Diagnostics based?
ReadyGo Diagnostics is headquartered in Chippenham, United Kingdom, in the Europe region.
How does ReadyGo Diagnostics make money?
Four revenue lines are on record. Diagnostic Device Sales are the primary driver. The others are goCollect® Collection Materials, goTest™ Reagent Delivery and OEM Development Services.
Who are ReadyGo Diagnostics's main competitors?
Direct peers on record are Genedrive, Binx Health, Sense Biodetection, QuantuMDx and OraSure Technologies. Broad incumbents are Cepheid (Danaher), Abbott (Diagnostics), bioMérieux and Hologic (Diagnostics). Sherlock Biosciences is listed as an emerging player.
Does ReadyGo Diagnostics have an API?
No public API is recorded for ReadyGo Diagnostics.
What industry is ReadyGo Diagnostics in?
ReadyGo Diagnostics's product category is Molecular Diagnostics Devices. Its primary akta.pro industry code is HLAHAAAN, Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics), with a secondary code of HLAHAAAM, IVD Reagents, Assay Kits & Consumables (Non-instrument). Its NAICS code is 325413 and its SIC code is 2835.